Women and Diabetes

Nursing Clinics of North America

Volumn 41, Issue 4, 2006, Pages 549-565

  Homko, Carol J ^a   Trout, Kimberly ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VILLANOVA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; FEMALE; HUMAN; MENOPAUSE; MENSTRUATION; MIDDLE AGED; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; HUMANS; MENOPAUSE; MENSTRUATION; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY IN DIABETICS; WOMEN'S HEALTH;

EID: 33750035178     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.07.004     Document Type: Review

References (80)

1. Kjaer K., Hagen C., Sando S.H., et al. Epidemiology of menarche and menstrual disturbances in a group of women with insulin dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 75 (1992) 524-529
2. Tatersall RB, Pyke DA. Growth in diabetic children: studies in identical twins. Lancet 1973;2:1105-9.
3. Salerno M., Argenziano A., DiMaio S., et al. Tenore maturation, and final height in children with IDDM: effects of age at onset and metcoli. Diabetes Care 20 (1997) 721-724
4. Strotmeyer E.S., Strotmeyer E.S., Steenkiste A.R., et al. Menstrual cycle differences with type 1 diabetes and women without diabetes. Diabetes Care 26 (2003) 1016-1021
5. Schriock E.A., Winter R.J., and Traisman H.S. Diabetes mellitus and its effects on menarche. J Adolesc Health Care 5 (1984) 101-104
6. Danielson K.K., Palta M., and Allen C. Wisconsin Diabetes Registry Project. J Clin Endocrinol Metab 90 (2005) 6466-6471
7. Pinhas-Hamiel O., Standiford D., Hamiel D., et al. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 153 (1999) 1063-1067
8. Ludwig D.S., and Ebbeling C.B. Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA 286 (2001) 1427-1430
9. Rosenbloom A.L., Joe J.R., Young R.S., et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22 (1999) 345-354
10. Thrailkill K.M. Diabetes care for adolescents. In: Reece E.A., Coustan D.R., and Gabbe S.G. (Eds). Diabetes in women: adolescence, pregnancy and menopause. 3rd edition (2004), Lippincott Williams & Wilkins, Philadelphia 37-56
11. ACOG Practice Bulletin #60: pregestational diabetes mellitus (2005), American College of Obstetricians and Gynecologists, Washington
12. Engelgau N.M., Herman W.H., Smith P.J., et al. The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 18 (1995) 1029-1033
13. Homko C.J., Sivan E., Reece E.A., et al. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 17 (1999) 119-125
14. Catalano P.M., Tyzbir E.D., Roman N.M., et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 165 (1991) 1667-1672
15. Reece E.A., Homko C.J., and Wu Y.K. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 54 (1996) 171-182
16. Eriksson U.J. Congenital malformations in diabetic animal models-a review. Diabetes Res 1 (1984) 57-61
17. Rose B.I., Graff S., Spencer R., et al. Major congenital anomalies in infants and glycosylated hemoglobin levels in insulin-requiring diabetic mothers. J Perinat 8 (1998) 309-311
18. Ylinen K., Aula P., Stenman U.H., et al. Risk of minor and major fetal malformations in diabetics with high hemoglobin A1c values in early pregnancy. BMJ 289 (1984) 345-346
19. Kitzmiller J.L., Gavin L.A., Gin G.D., et al. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265 (1991) 731-736
20. Kitzsmiller J.L., Buchanan T.A., Kjos S., et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19 (1996) 514-541
21. Metzger B.E., and Coustan D.R. Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes. Diabetes Care 21 Suppl 2 (1998) B161-B167
22. Marshall J.A., Hamman R.F., Baxter J., et al. Ethnic differences in risk factors associated with prevalence of non-insulin dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol 137 (1993) 706-718
23. ACOG Practice Bulletin #30: gestational diabetes (2001), American College of Obstetricians and Gynecologists, Washington
24. Homko C.J. Woman and diabetes. In: Childs B.P., Cypress M., and Spollett G. (Eds). Complete nurse's guide to diabetes care (2005), American Diabetes Association, Alexandria 272-285
25. Hollingsworth D.R., and Moore T.R. Postprandial walking exercise in pregnant insulin dependent (type I) diabetic women: reduction of plasma lipid levels but absence of a significant effect on glycemic control. Am J Obstet Gynecol 157 (1987) 1359-1363
26. Jovanovic-Peterson L., and Peterson C.M. Exercise and the nutritional management of diabetes during pregnancy. Obstet Gynecol Clin North Am 23 (1996) 75-86
27. Bung P., Artal R., Khodiguian N., et al. Exercise in gestational diabetes: an optional therapeutic approach?. Diabetes 40 Suppl 2 (1991) 182-185
28. Bhattacharyya A., Brown S., Hughes S., et al. Insulin lispro and regular insulin in pregnancy. QJM 94 (2001) 255-260
29. Jovanovic L., Ilic S., Pettitt D.J., et al. Metabolic and Immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 22 (1999) 1422-1427
30. Wyatt J.W., Frias J.L., Hoyme H.E., et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 22 (2004) 803-807
31. Jornsay D.L. Pregnancy and continuous insulin infusion therapy. Diabetes Spectrum 11 (1998) 26-32
32. Langer O., Conway D.L., Berkus M., et al. A comparison of glyburide and insulin in women with GDM. N Engl J Med 343 (2000) 1134-1138
33. Kremer C.J., and Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 190 (2004) 1438-1439
34. Chmait R., Dinise T., and Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 24 (2004) 617-622
35. Jacobson G.F., Ramos G.A., Ching J.Y., et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 193 (2005) 118-124
36. Weintrob N., Karp M., and Hod M. Short- and long-range complications in offspring of diabetic mothers. J Diabetes Complications 10 (1996) 294-301
37. Schwarz R., and Teramo K.A. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatal 24 (2000) 120-135
38. Van Geusekon C.M., Annnet Zeegers T., Martini I.A., et al. Milk of patients with tightly controlled insulin-dependent diabetes mellitus has normal macronutrient and fatty acid composition. Am J Clin Nutr 57 (1993) 938-943
39. von Kries R., Koletzko B., Sauerwald T., et al. Breast feeding and obesity: cross sectional study. BMJ 319 (1999) 47-150
40. Arstrong J., and Reilly J.J. Breastfeeding and lowering the risk of childhood obesity. Lancet 359 (2002) 2003-2004
41. Pettitt D.J., and Knowler W.C. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 21 Suppl 2 (1998) B138-B141
42. Kjos S.L., Henry O., Lee T.M., et al. The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 82 (1993) 451-455
43. Stuebe A.M., Rich-Edwards J.W., Willett W.C., et al. Duration of lactation and incidence of type 2 diabetes. JAMA 294 (2005) 2601-2610
44. Kjos S.L. Contraception in women with diabetes mellitus. Diabetes Spectrum 6 (1993) 80-86
45. Kjos S.L. Postpartum care of women with diabetes. Clin Obstet Gynecol 43 (2000) 46-55
46. Kjos S.L., Peters R.K., Xiang A., et al. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280 (1998) 533-538
47. Case A., and Reid R.L. Effects of the menstrual cycle on medical disorders. Arch Intern Med 158 (1998) 1405-1412
48. Cawood E.H., Bancroft J., and Steel J.M. Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med 10 (1993) 444-448
49. Cramer H.I. The influence of menstruation on carbohydrate tolerance in diabetes mellitus. Can Med Assoc J 47 (1942) 51-55
50. Jarrett R.J., and Graver H.J. Changes in oral glucose tolerance during the menstrual cycle. BMJ 2 (1968) 528-529
51. Moberg E., Kollind M., Lins P.E., et al. Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle. Diabet Med 12 (1995) 224-228
52. Widom B., Diamond M.P., and Simonson D.C. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care 15 (1992) 213-220
53. Trout K.K., Rickels M., Petrova M., et al. Menstrual cycle effects on insulin sensitivity in women with type 1 diabetes. [abstract]. Diabetes 54 (2005) A645
54. Goldner W.S., Kraus V.L., Sivitz W.I., et al. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther 6 (2004) 473-480
55. Legro R.S., and Azziz R. Androgen excess disorders. In: Scott J.R., Gibbs R.S., Kaplan B.Y., et al. (Eds). Danforth's obstetrics and gynecology. 9th edition (2003), Lippincott Williams & Wilkins, Philadelphia 669-672
56. Bloomgarden Z.T. Diabetes issues in women and children. Diabetes Care 26 (2003) 2457-2463
57. Bjercke S., Dale P.O., Tanbo T., et al. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 54 (2002) 94-98
58. Mikola M., Hilesmaa V., Haltunen M., et al. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 16 (2001) 226-229
59. Costello M.F., and Eden J.A. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 79 (2003) 1-13
60. Lord J.M., Flight I.H.K., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327 (2003) 951-957
61. Glucek C.J., Wang P., Kobayashi S., et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 77 (2002) 520-525
62. Glueck C.J., Wang P., Goldenberg N., et al. Pregnancy outcomes among women with polycystic ovarian syndrome treated with metformin. Hum Reprod 17 (2002) 2858-2864
63. Glueck C.J., Goldenberg N., Wang P., et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19 (2004) 510-521
64. Vanky E., Salvesen K.A., Helmstad R., et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 19 (2004) 1734-1740
65. Dorman J.S., Steenkiste A.R., Foley T.P., et al. Menopause in type 1 diabetic women. Is it premature?. Diabetes 50 (2001) 1857-1862
66. Eisenberg E. Menopause and diabetes. In: Reece E.A., Coustan D.R., and Gabbe S.G. (Eds). Diabetes in women: adolescence, pregnancy and menopause. 3rd edition (2004), Lippincott Williams & Wilkins, Philadelphia 441-450
67. Malacara J.M., Huerta R., Rivera B., et al. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile. Maturitas 28 (1997) 35-45
68. Lopez-Lopez R., Huerta R., and Malacara J.M. Age at menopause in women with type 2 diabetes mellitus. Menopause 6 (1999) 174-178
69. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) research group. JAMA 280 (1998) 605-613
70. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
71. Crespo C.J., Smit E., Snelling A., et al. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and non-diabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 25 (2002) 1675-1680
72. Giardina E.G. Call to action: cardiovascular disease in women. J Womens Health 7 (1998) 37-43
73. Lundberg V., Stegmayr B., Asplund K., et al. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med 241 (1997) 485-492
74. Howard B.V., Cowan L.D., Go O., et al. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 18 (1998) 1258-1265
75. Barrett-Connor E., and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21 (1998) 1236-1239
76. Albert C. Sex differences in cardiac arrest survivors. Circulation 93 (1996) 1170-1176
77. Berra K. Women, coronary heart disease and dyslipidemia: does gender alter detection, evaluation or therapy?. J Cardiovasc Nurs 14 (2000) 59-78
78. Tuominen J.T., Impivaara L., Puukka P., et al. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22 (1999) 1196-1200
79. Olmos J.M., Gonzalez-Castrillon J.J.L., Garcia M.T., et al. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner 26 (1994) 1-8
80. Schwartz A.V. Diabetes mellitus: does it affect bone?. Calcif Tissue Int 73 (2003) 515-519